WIN 2022 Program

Saturday 29 October 2022

Sunday 30 October 2022

INTEGRATING GENOMICS AND TRANSCRIPTOMICS TO RESHAPE PRECISION ONCOLOGY: A WINNING STRATEGY
Sunday 30 October 2022
SESSION 3 – DISRUPTIVE CONCEPTS AND METHODOLOGICAL INNOVATIONS IN NSCLC: MEET THE EXPERTS Chair: Pierre Saintigny, Centre Léon Bérard, Lyon, France Gerald Batist, Segal Cancer Center, Canada
	08:30 Keynote Lecture Overview of advances in lung cancer View the presentation	Enriqueta Felip	Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
	08:55 From chest x ray to AI-assisted lung cancer screening and early detection program in Israel View the presentation	Amir Onn	Sheba Medical Center, Ramat Gan, Israel
	09:20 Individualized surgical treatment strategy for early-stage lung cancer: Translation of knowledge Watch the presentation	Haiquan Chen	Fudan University, Shanghai, China
	09:45 Neoadjuvant and adjuvant strategies in NSCLC View the presentation	Jair Bar	Sheba Medical Center, Ramat Gan, Israel
	10:10 New drugs for SCLC View the presentation	Pilar Garrido	Universidad de Alcalá, Madrid, Spain
10:35	Panel Discussion and Q&A from the Audience
11:00 Coffee and Networking
SESSION 4 - WIN FIRST INTERNATIONAL MOLECULAR TUMOR BOARD: A STRATEGIC PLACE IN ADVANCING PRECISION ONCOLOGY
	11:30 First WIN International Molecular Tumor Board Introduction Patients' cases presentation by investigators. Panel discussion and Q&A from audience. View the presentation	Moderator: Razelle Kurzrock	WIN Consortium, Chevilly-Larue, France
		Case Reports presentation: Wafik S. El-Deiry	Legorreta Cancer Center at Brown University, Providence, USA
		Maria Vieito	VHIO, Barcelona, Spain
		Panel: Vivek Subbiah	The University of Texas, MD Anderson Cancer Center, USA
		Enriqueta Felip	VHIO, Barcelona, Spain
		Ulrik Lassen	Rigshospitalet, Copenhagen, Denmark
12:35 Panel Discussion and Q&A from the audience
13:00 Lunch, poster viewing and networking
SESSION 5 – WHAT IS NEW IN BREAST, CRC, HEAD & NECK, AND PEDIATRIC CANCERS? Chairs: Michel Ducreux, Gustave Roussy, France Ulrik Lassen, Rigshospitalet, Denmark
	14:00 Opening Keynote Lecture Precision medicine for patients with metastatic breast cancer View the presentation	Fabrice André	Gustave Roussy, Villejuif, France
	14:25 Keynote Lecture Novel CRC insights based on combined genomic and transcriptomic data at both bulk and single cell level, leading to new therapeutically relevant CRC classification	Sabine Tejpar	University of Leuven, Belgium
	14:50 Beyond the tip of the iceberg: proteomic analysis in colon and breast cancer View the presentation	Gerald Batist	Segal Cancer Centre, Lady Davis Institute at the JGH, McGill University, Montréal, Canada
	15:15 Proteogenomic analysis of triple negative breast cancer (TNBC) response to neoadjuvant chemotherapy View the presentation	Matthew Ellis	AstraZeneca, Gaithersburg, Maryland, USA
	15:40 Novel strategies in head & neck cancers View the presentation	Christophe Le Tourneau	Institut Curie, Paris, France
	16:05 Pediatric European Precision Cancer Medicine Program - Facing cancer complexity View the presentation	Birgit Geoerger	Gustave Roussy, Villejuif, France ITCC
16:30 Panel Discussion and Q&A from the audience
16:55 BEST TWO POSTERS' PRESENTATIONS AND AWARDS Josep Tabernero, Vice-Chairman WIN Consortium, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain Amir Onn, Head of the Standard Operating Procedures and repository Committee WIN Consortium Chair, Institute of Pulmonary Medicine, Sheba Medical Center, Israel
17:20 CONCLUSIONS Richard L. Schilsky, Chairman WIN Consortium